Here, we compared the effects of ARID1A depletion and re‐expression in normal‐like and tumor‐like urothelial bladder cell models to gain further insight regarding the consequences of ARID1A inactivation and to identify pathways that might serve as possible targets for treatment. The gene discussed is ARID1A; the disease is neoplasm.